Rodman & Renshaw
http://www.rodmanandrenshaw.com/Rodman & Renshaw is an investment bank. The firm provides investment banking services to companies that have significant recurring capital needs along with research, sales, and trading services to institutional investors. The firm focuses on the biotechnology sector and since 2003 has been a leading investment bank to the sector. The firm is also a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
-
Notable Analyst Rating Changes 01/20: FFIV, MU, SHAW, XLNX Upgraded; RAX, STX, NETL, MNKD Downgraded
-
Rodman & Renshaw Downgrades MannKind (MNKD) to Market Perform
-
Analyst Sees MannKind (MNKD) Shares Doubling If Afrezza Wins FDA Approval Soon
-
Rodman & Renshaw Maintains Positive Stance On MannKind's (MNKD) Afresa
-
Rodman & Renshaw Reiterates a Market Outperform rating on MannKind (MNKD); Sees Upside Surprise
-
Rodman & Renshaw Resumes Coverage on MannKind (MNKD) with a Market Outperform
-
Rodman & Renshaw Initiates Coverage on MannKind (MNKD) with a Market Outperform
